Invesco Ltd.

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$215,557

+$56,503 QoQ

Shares Held

20,687

+153.6% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 95 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 98% None 2%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. RNAC ranks #238 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$215,557	20,687	-91.5%	Shares	Defined	2026-08-14
2024-03-31	$159,054	244,699	+348.6%	Shares	Defined	2024-05-14
2023-12-31	$37,578	54,542	-30.1%	Shares	Defined	2024-02-13
2023-09-30	$82,718	78,037	-1.5%	Shares	Defined	2023-11-13
2023-06-30	$88,734	79,228	+294.4%	Shares	Defined	2023-08-11
2023-03-31	$27,922	20,088	-3.3%	Shares	Defined	2023-05-12
2022-12-31	$23,481	20,780	-30.7%	Shares	Defined	2023-02-13
2022-03-31	$36,861	29,969	+6.2%	Shares	Defined	2022-05-16
2021-12-31	$91,953	28,207	-15.4%	Shares	Defined	2022-02-14
2021-09-30	$138,764	33,357	+14.5%	Shares	Defined	2021-11-15
2021-06-30	$121,795	29,138	+9.5%	Shares	Defined	2021-08-17
2021-03-31	$120,437	26,616	+7.7%	Shares	Defined	2021-05-17
2020-12-31	$74,910	24,723	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.